{"transactions":[{"id":793772,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":49952,"kind":"person","name":"Fowler Neal Franklin","position":1,"cik":"0001493692","reported_name":"Fowler Neal Franklin","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-05-04T21:27:43.000Z","date":"2026-04-30","kind":"grant","planned":false,"acquired":true,"shares":11296,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Consists of stock options granted under the Company's Stock Incentive Plan, as amended and restated, for Board and Committee service. The shares underlying the options will vest on the Annual Grant Vesting Date, subject to the reporting person remaining a member of the Company's board of directors through the Annual Grant Vesting Date. Each stock option represents a right to purchase one share of the Company's common stock upon vesting at the exercise price."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F3","text":"The number of options granted was determined by multiplying 25% of the total non-employee director compensation value, and then dividing by the Black-Scholes value of a single option calculated as of the date of the grant."}],"balance_after":11296,"derivative":{"exercise_price":7.99,"expiration_date":"2033-04-30","underlying":"Common Stock","underlying_shares":11296},"source":{"system":"sec-edgar","filing":"0001493692-26-000003","document":"wk-form4_1777930061.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1493692/000149369226000003/wk-form4_1777930061.xml","form_type":"4"}},{"id":793771,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":49952,"kind":"person","name":"Fowler Neal Franklin","position":1,"cik":"0001493692","reported_name":"Fowler Neal Franklin","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-05-04T21:27:43.000Z","date":"2026-04-30","kind":"grant","planned":false,"acquired":true,"shares":25344,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents an annual grant of restricted stock units (\"RSUs\") granted under the Company's Stock Incentive plan, as amended and restated, for Board and Committee service. Each RSU represents a right to receive one share of Emergent BioSolutions Inc. (the \"Company\") common stock upon vesting. The shares underlying the RSUs will vest on the day prior to the one-year anniversary of the grant date (\"Annual Grant Vesting Date\"), subject to the reporting person remaining a member of the Company's board of directors through the Annual Grant Vesting Date."}],"balance_after":160847,"source":{"system":"sec-edgar","filing":"0001493692-26-000003","document":"wk-form4_1777930061.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1493692/000149369226000003/wk-form4_1777930061.xml","form_type":"4"}},{"id":1161136,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":49952,"kind":"person","name":"Fowler Neal Franklin","position":1,"cik":"0001493692","reported_name":"Fowler Neal Franklin","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-05-03T00:31:22.000Z","date":"2025-04-30","kind":"grant","planned":false,"acquired":true,"shares":15824,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Consists of stock options granted under the Company's Stock Incentive Plan, as amended and restated, for Board and Committee service. The shares underlying the options will vest on the Annual Grant Vesting Date, subject to the reporting person remaining a member of the Company's board of directors through the Annual Grant Vesting Date. Each stock option represents a right to purchase one share of the Company's common stock upon vesting at the exercise price."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F3","text":"The number of options granted was determined by multiplying 25% of the total non-employee director compensation value, and then dividing by the Black-Scholes value of a single option calculated as of the date of the grant."}],"balance_after":41572,"derivative":{"exercise_price":5.45,"expiration_date":"2032-04-29","underlying":"Common Stock","underlying_shares":15824},"source":{"system":"sec-edgar","filing":"0001367644-25-000109","document":"wk-form4_1746232276.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1493692/000136764425000109/wk-form4_1746232276.xml","form_type":"4"}},{"id":1161135,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":49952,"kind":"person","name":"Fowler Neal Franklin","position":1,"cik":"0001493692","reported_name":"Fowler Neal Franklin","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-05-03T00:31:22.000Z","date":"2025-04-30","kind":"grant","planned":false,"acquired":true,"shares":34403,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents an annual grant of restricted stock units (\"RSUs\") granted under the Company's Stock Incentive plan, as amended and restated, for Board and Committee service. Each RSU represents a right to receive one share of Emergent BioSolutions Inc. (the \"Company\") common stock upon vesting. The shares underlying the RSUs will vest on the day prior to the one-year anniversary of the grant date (\"Annual Grant Vesting Date\"), subject to the reporting person remaining a member of the Company's board of directors through the Annual Grant Vesting Date."}],"balance_after":135503,"source":{"system":"sec-edgar","filing":"0001367644-25-000109","document":"wk-form4_1746232276.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1493692/000136764425000109/wk-form4_1746232276.xml","form_type":"4"}},{"id":1209561,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":49952,"kind":"person","name":"Fowler Neal Franklin","position":1,"cik":"0001493692","reported_name":"Fowler Neal Franklin","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-03-12T22:13:19.000Z","date":"2025-03-12","kind":"sale","planned":false,"acquired":false,"shares":35000,"price":5.83,"value":204050.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On March 12, 2025, Mr. Fowler sold an aggregate of 35,000 shares of Emergent BioSolutions Inc. common stock. For reporting purposes, the sales prices within a $1 range have been aggregated and the weighted average sales price has been reported. The price ranges were: $5.81 to $5.89. The Company maintains a record of the transactions and copies will be provided upon request."}],"balance_after":101100,"source":{"system":"sec-edgar","filing":"0001367644-25-000060","document":"wk-form4_1741817592.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1493692/000136764425000060/wk-form4_1741817592.xml","form_type":"4"}},{"id":1500338,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":49952,"kind":"person","name":"Fowler Neal Franklin","position":1,"cik":"0001493692","reported_name":"Fowler Neal Franklin","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-05-29T01:41:15.000Z","date":"2024-05-23","kind":"grant","planned":false,"acquired":true,"shares":25748,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Consists of stock options granted under the Company's Stock Incentive Plan, as amended and restated, for Board and Committee service. The shares underlying the options will vest on the Annual Grant Vesting Date, subject to the reporting person remaining a member of the Company's board of directors through the Annual Grant Vesting Date. Each stock option represents a right to purchase one share of the Company's common stock upon vesting at the exercise price."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F3","text":"The number of options granted was determined by dividing half of the total non-employee director compensation value by the Black-Scholes value of a single option calculated as of the date of the grant."}],"balance_after":25748,"derivative":{"exercise_price":5.02,"expiration_date":"2031-05-22","underlying":"Common Stock","underlying_shares":25748},"source":{"system":"sec-edgar","filing":"0001367644-24-000088","document":"wk-form4_1716946866.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1493692/000136764424000088/wk-form4_1716946866.xml","form_type":"4"}},{"id":1500337,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":49952,"kind":"person","name":"Fowler Neal Franklin","position":1,"cik":"0001493692","reported_name":"Fowler Neal Franklin","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-05-29T01:41:15.000Z","date":"2024-05-23","kind":"grant","planned":false,"acquired":true,"shares":17430,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents an annual grant of restricted stock units (\"RSUs\") granted under the Company's Stock Incentive plan, as amended and restated, for Board and Committee service. Each RSU represents a right to receive one share of Emergent BioSolutions Inc. (the \"Company\") common stock upon vesting. The shares underlying the RSUs will vest on the day prior to the one-year anniversary of the grant date (\"Annual Grant Vesting Date\"), subject to the reporting person remaining a member of the Company's board of directors through the Annual Grant Vesting Date."}],"balance_after":136100,"source":{"system":"sec-edgar","filing":"0001367644-24-000088","document":"wk-form4_1716946866.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1493692/000136764424000088/wk-form4_1716946866.xml","form_type":"4"}},{"id":1764331,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":49952,"kind":"person","name":"Fowler Neal Franklin","position":1,"cik":"0001493692","reported_name":"Fowler Neal Franklin","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-10-05T23:10:23.000Z","date":"2023-10-03","kind":"grant","planned":false,"acquired":true,"shares":118670,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Consists of restricted stock units granted under the Company's Stock Incentive Plan, as amended and restated. These restricted stock units will vest in three equal installments over a three-year period assuming continued service with the Company. Each restricted stock unit represents the right of the Reporting Person to receive one share of common stock of Emergent BioSolutions Inc., subject to adjustment as provided in the grant agreement."}],"balance_after":118670,"source":{"system":"sec-edgar","filing":"0001367644-23-000179","document":"wk-form4_1696547413.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1493692/000136764423000179/wk-form4_1696547413.xml","form_type":"4"}},{"id":2971208,"issuer":{"id":1860,"kind":"organization","name":"Liquidia Corp","symbol":"LQDA"},"owners":[{"id":49952,"kind":"person","name":"Fowler Neal Franklin","position":1,"cik":"0001493692","reported_name":"Fowler Neal Franklin","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2020-11-20T23:45:18.000Z","date":"2020-11-19","kind":"exercise","acquired":false,"shares":62885,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the shares underlying the option vested on May 12, 2011, and 2.084% of the shares underlying the option vested monthly thereafter, becoming fully vested on November 23, 2014."}],"balance_after":0,"derivative":{"exercise_price":1.85,"expiration_date":"2020-11-23","underlying":"Common Stock","underlying_shares":62885},"source":{"system":"sec-edgar","filing":"0001104659-20-128078","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1493692/000110465920128078/a4.xml","form_type":"4"}},{"id":2971207,"issuer":{"id":1860,"kind":"organization","name":"Liquidia Corp","symbol":"LQDA"},"owners":[{"id":49952,"kind":"person","name":"Fowler Neal Franklin","position":1,"cik":"0001493692","reported_name":"Fowler Neal Franklin","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2020-11-20T23:45:18.000Z","date":"2020-11-19","kind":"tax_withholding","acquired":false,"shares":35684,"price":3.4,"value":121325.6,"ownership":{"direct":true},"balance_after":78512,"source":{"system":"sec-edgar","filing":"0001104659-20-128078","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1493692/000110465920128078/a4.xml","form_type":"4"}},{"id":2971206,"issuer":{"id":1860,"kind":"organization","name":"Liquidia Corp","symbol":"LQDA"},"owners":[{"id":49952,"kind":"person","name":"Fowler Neal Franklin","position":1,"cik":"0001493692","reported_name":"Fowler Neal Franklin","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2020-11-20T23:45:18.000Z","date":"2020-11-19","kind":"exercise","acquired":true,"shares":62885,"price":1.85,"value":116337.25,"ownership":{"direct":true},"balance_after":114196,"source":{"system":"sec-edgar","filing":"0001104659-20-128078","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1493692/000110465920128078/a4.xml","form_type":"4"}},{"id":3199443,"issuer":{"id":145051,"kind":"organization","name":"Liquidia Technologies Inc","symbol":"LQDA"},"owners":[{"id":49952,"kind":"person","name":"Fowler Neal Franklin","position":1,"cik":"0001493692","reported_name":"Fowler Neal Franklin","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Employee Stock Option (right to buy","published_at":"2020-03-20T23:08:37.000Z","date":"2020-03-18","kind":"grant","acquired":true,"shares":121600,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option vests in equal monthly installments over a four-year period, becoming fully vested on March 18, 2024."}],"balance_after":121600,"derivative":{"exercise_price":3.31,"exercise_date":"2020-04-18","expiration_date":"2030-03-18","underlying":"Common Stock","underlying_shares":121600},"source":{"system":"sec-edgar","filing":"0001104659-20-036983","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1493692/000110465920036983/a4.xml","form_type":"4"}},{"id":3199442,"issuer":{"id":145051,"kind":"organization","name":"Liquidia Technologies Inc","symbol":"LQDA"},"owners":[{"id":49952,"kind":"person","name":"Fowler Neal Franklin","position":1,"cik":"0001493692","reported_name":"Fowler Neal Franklin","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2020-03-20T23:08:37.000Z","date":"2020-03-18","kind":"grant","acquired":true,"shares":30400,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The restricted stock units (RSUs) vest and settle into common stock over a four-year period with 25% of the RSUs vesting and settling into common stock on the one year anniversary of the grant date and the remaining 75% of the RSUs vesting and settling into common stock in equal quarterly installments over the next three years, becoming fully vested on March 18, 2024."}],"balance_after":86627,"source":{"system":"sec-edgar","filing":"0001104659-20-036983","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1493692/000110465920036983/a4.xml","form_type":"4"}},{"id":3670382,"issuer":{"id":145051,"kind":"organization","name":"Liquidia Technologies Inc","symbol":"LQDA"},"owners":[{"id":49952,"kind":"person","name":"Fowler Neal Franklin","position":1,"cik":"0001493692","reported_name":"Fowler Neal Franklin","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2019-02-07T22:11:53.000Z","date":"2019-02-05","kind":"grant","acquired":true,"shares":96500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests over a four-year period with 25% of the shares of common stock underlying the option vesting on the one year anniversary of the grant date and the remaining 75% of the shares of common stock underlying the option vesting in equal monthly installments thereafter, becoming fully vested on February 5, 2023."}],"balance_after":96500,"derivative":{"exercise_price":14.2,"expiration_date":"2029-02-05","underlying":"Common Stock","underlying_shares":96500},"source":{"system":"sec-edgar","filing":"0001104659-19-006376","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1493692/000110465919006376/a4.xml","form_type":"4"}},{"id":3789817,"issuer":{"id":145051,"kind":"organization","name":"Liquidia Technologies Inc","symbol":"LQDA"},"owners":[{"id":49952,"kind":"person","name":"Fowler Neal Franklin","position":1,"cik":"0001493692","reported_name":"Fowler Neal Franklin","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2018-10-16T20:06:25.000Z","date":"2018-10-12","kind":"grant","acquired":true,"shares":11238,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes (i) 44,989 shares of common stock and (ii) 11,238 restricted stock units (\"RSUs\") granted on October 12, 2018 which shall be settled into common stock pursuant to the following vesting schedule: 25% of the RSUs shall vest on August 14, 2019, with the remaining 75% of such RSUs vesting in 36 equal monthly installments thereafter, subject to Mr. Fowler's continuous service as of each such date."}],"balance_after":56227,"source":{"system":"sec-edgar","filing":"0001104659-18-062291","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1493692/000110465918062291/a4.xml","form_type":"4"}},{"id":3859939,"issuer":{"id":145051,"kind":"organization","name":"Liquidia Technologies Inc","symbol":"LQDA"},"owners":[{"id":49952,"kind":"person","name":"Fowler Neal Franklin","position":1,"cik":"0001493692","reported_name":"Fowler Neal Franklin","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option","published_at":"2018-07-27T21:02:08.000Z","date":"2018-07-25","kind":"grant","acquired":true,"shares":192008,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of such options vest on July 25, 2019, with the remainder vesting in 36 equal monthly installments after July 25, 2019, subject to Mr. Fowler's continuous service as of each such date."}],"balance_after":192008,"derivative":{"exercise_price":11,"exercise_date":"2019-07-25","expiration_date":"2028-07-25","underlying":"Common Stock","underlying_shares":192008},"source":{"system":"sec-edgar","filing":"0001104659-18-047751","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1493692/000110465918047751/a4.xml","form_type":"4"}},{"id":4322710,"issuer":{"id":165961,"kind":"organization","name":"Aralez Pharmaceuticals Inc.","symbol":"ARLZ"},"owners":[{"id":49952,"kind":"person","name":"Fowler Neal Franklin","position":1,"cik":"0001493692","reported_name":"Fowler Neal Franklin","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (right to buy)","published_at":"2017-05-13T01:50:42.000Z","date":"2017-05-11","kind":"grant","acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option vests in one installment on May 11, 2018, subject to the director's continued service on the Board as of such date."}],"balance_after":15000,"derivative":{"exercise_price":1.56,"expiration_date":"2027-05-11","underlying":"Common Shares, without par value","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001104659-17-032407","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1493692/000110465917032407/a4.xml","form_type":"4"}},{"id":4322709,"issuer":{"id":165961,"kind":"organization","name":"Aralez Pharmaceuticals Inc.","symbol":"ARLZ"},"owners":[{"id":49952,"kind":"person","name":"Fowler Neal Franklin","position":1,"cik":"0001493692","reported_name":"Fowler Neal Franklin","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares, without par value","published_at":"2017-05-13T01:50:42.000Z","date":"2017-05-11","kind":"grant","acquired":true,"shares":7500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Restricted Stock Units, all of which vest on May 11, 2018, subject to the director's continued service on the Board as of such date.  Vested shares will be delivered to the Reporting Person on the earlier of the date that the Reporting Person ceases to provide services to the Board and the date of a Change of Control, as defined in the Issuer's 2016 Amended and Restated Long-Term Incentive Plan, in either case provided that the Restricted Stock Units are vested on such date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 66,369 shares of Common Stock and 7,500 Restricted Stock Units."}],"balance_after":73869,"source":{"system":"sec-edgar","filing":"0001104659-17-032407","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1493692/000110465917032407/a4.xml","form_type":"4"}}]}